{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:48:55Z","timestamp":1787993335363,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The severity of chronic hepatitis C and susceptibility to hepatocellular carcinoma (HCC) are associated with genetic variations within vitamin D receptor (VDR) in several populations. This study aims to determine the significance of the VDRs (rs2228570, rs3782905, rs11568820) and DBP (rs7041) for the susceptibility to HCC in Egyptian patients with chronic HCV infection and their effect on the progression of liver cirrhosis to carcinogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single nucleotide polymorphisms (SNPs) VDR (rs2228570, rs3782905), and DBP rs7041 were genotyped using restriction fragment length-PCR (RFLP-PCR) technique and VDR rs11568820 was genotyped using single strand polymorphism PCR (SSP PCR). These SNPs genotypes, haplotypes and linkage disequilibrium analyses were examined in 299 Egyptian individuals (100 HCV-cirrhotic patients, 99 HCC- HCV patients, and 100 healthy controls).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The VDR rs2228570 CC genotype, VDR rs3782905 GC and CC genotypes, and DBP rs7041 GG genotype are significantly higher in HCC. It is noteworthy that, VDR rs3782905 CC and DBP rs7041 TG genotypes are higher in HCV induced liver cirrhosis than with HCC progression in HCV infected patients. Furthermore, among patients, the relationship between these SNPs and smoking status, gender, and HCC susceptibility was reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among the four investigated SNPs, there are associations between VDR rs3782905 and DBP rs7041 and the HCC progression in Egyptian patients chronically infected with HCV. These SNPs are considered as risk factors in HCV induced liver cirrhosis and HCC. The combinations of these SNPs with smoking status and gender are statistically linked to a high risk of HCC. Future research with a larger sample size of subjects with HCV infection is advised, because chronic liver disease induced by HCV infection is the primary cause of HCC in Egypt. We recommend screening of these SNPs for prediction of LC and HCC development in HCV infected patients, which may improve the used therapeutic protocol. These results suggest that VDR polymorphisms may be potential determinants for HCC susceptibility in Egyptian HCV patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01749-8","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T03:02:11Z","timestamp":1702004531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Asmaa Samir","family":"El-masry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina M.","family":"Medhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Bendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-9550","authenticated-orcid":false,"given":"Rania Hassan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40364-021-00350-4","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang W, Jiang L, Chen Y. Recent advances in systemic therapy for hepatocellular carcinoma. Biomark Res. 2022;10:3. https:\/\/doi.org\/10.1186\/s40364-021-00350-4.","journal-title":"Biomark Res"},{"key":"1749_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1749_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43046-020-0016-x","volume":"32","author":"WM Rashed","year":"2020","unstructured":"Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst. 2020;32(1):5. https:\/\/doi.org\/10.1186\/s43046-020-0016-x.","journal-title":"J Egypt Natl Canc Inst"},{"key":"1749_CR4","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/ijms22041799","volume":"22","author":"J Wei","year":"2021","unstructured":"Wei J, Fang D. Endoplasmic reticulum stress signaling and the pathogenesis of hepatocarcinoma. Int J Mol Sci. 2021;22:1799. https:\/\/doi.org\/10.3390\/ijms22041799.","journal-title":"Int J Mol Sci"},{"key":"1749_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/17474124.2020.1823215","volume":"14","author":"K Farid","year":"2020","unstructured":"Farid K, Elalfy H, Abo El-Khair SM, Elgamal H, Besheer T, Elmokadem A, et al. Prognostic value of vascular endothelial growth factor in both conventional and drug-eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Rev Gastroenterol Hepatol. 2020;14:1203\u201314. https:\/\/doi.org\/10.1080\/17474124.2020.1823215.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"1749_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","volume":"9","author":"JD Yang","year":"2011","unstructured":"Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9(1):64\u201370. https:\/\/doi.org\/10.1016\/j.cgh.2010.08.019.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1749_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2019.01.004","volume":"9","author":"A Jindal","year":"2019","unstructured":"Jindal A, Thadi A, Shailubhai K. Hepatocellular carcinoma: etiology and current and future drugs. J Clin Exp Hepatol. 2019;9:221\u201332. https:\/\/doi.org\/10.1016\/j.jceh.2019.01.004.","journal-title":"J Clin Exp Hepatol"},{"key":"1749_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention, and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1749_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","volume":"88","author":"DL Kamen","year":"2010","unstructured":"Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441\u201350. https:\/\/doi.org\/10.1007\/s00109-010-0590-9.","journal-title":"J Mol Med (Berl)"},{"key":"1749_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2010.03.019","volume":"121","author":"MR Haussler","year":"2010","unstructured":"Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the \u201cFountain of Youth\u201d to mediate healthful aging. J Steroid Biochem Mol Biol. 2010;121:88\u201397. https:\/\/doi.org\/10.1016\/j.jsbmb.2010.03.019.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1749_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21608\/smj.2019.40879","volume":"23","author":"A Abudeif","year":"2019","unstructured":"Abudeif A, Galal G, Mohammad A, Agamy M, Ahmad N, Fahmy N. VDR gene polymorphisms and risk of hepatocellular carcinoma. Sohag Med J. 2019;23:24\u201330. https:\/\/doi.org\/10.21608\/smj.2019.40879.","journal-title":"Sohag Med J"},{"key":"1749_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1023\/B:JOCI.0000040923.07879.31","volume":"24","author":"P Selvaraj","year":"2004","unstructured":"Selvaraj P, Chandra G, Jawahar MS, Rani MV, Rajeshwari DN, Narayanan PR. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol. 2004;24:523\u201332. https:\/\/doi.org\/10.1023\/B:JOCI.0000040923.07879.31.","journal-title":"J Clin Immunol"},{"key":"1749_CR13","doi-asserted-by":"publisher","first-page":"6239158","DOI":"10.1155\/2018\/6239158","volume":"2018","author":"NA Abdella","year":"2018","unstructured":"Abdella NA, Mojiminiyi OA. Vitamin D-binding protein clearance ratio is significantly associated with glycemic status and diabetes complications in a predominantly vitamin D-deficient population. J Diabetes Res. 2018;2018:6239158. https:\/\/doi.org\/10.1155\/2018\/6239158.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1749_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1210\/jc.2010-0980","volume":"96","author":"KM Thrailkill","year":"2011","unstructured":"Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab. 2011;96(1):142\u20139. https:\/\/doi.org\/10.1210\/jc.2010-0980.","journal-title":"J Clin Endocrinol Metab"},{"key":"1749_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2006.03.011","volume":"372","author":"M Speeckaert","year":"2006","unstructured":"Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006;372:33\u201342. https:\/\/doi.org\/10.1016\/j.cca.2006.03.011.","journal-title":"Clin Chim Acta"},{"key":"1749_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pone.0126359","volume":"10","author":"R Jorde","year":"2015","unstructured":"Jorde R, Schirmer H, Wilsgaard T, Mathiesen EB, Nj\u00f8lstad I, L\u00f8chen ML, et al. The DBP phenotype Gc-1f\/Gc-1f is associated with reduced risk of cancer. The Troms\u00f8 study. PLos One. 2015;10:5. https:\/\/doi.org\/10.1371\/journal.pone.0126359.","journal-title":"PLos One"},{"key":"1749_CR17","doi-asserted-by":"publisher","unstructured":"Jiawei R, Xukun Wu, Xiaozhuan Z, Ronghai D and YiMa. Vitamin D Receptor FokI Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepta Mon. 2018. https:\/\/doi.org\/10.5812\/heptamon.85075.","DOI":"10.5812\/heptamon.85075"},{"key":"1749_CR18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3332\/ecancer.2022.1383","volume":"16","author":"B Brait","year":"2022","unstructured":"Brait B, Silva SB, Aguiar FL, Ferreira R, Brancat C, Brancati O, et al. Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC). Ecancer Medicalscience. 2022;16:1383. https:\/\/doi.org\/10.3332\/ecancer.2022.1383.","journal-title":"Ecancer Medicalscience"},{"key":"1749_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms2409822","author":"E Tourkochristou","year":"2023","unstructured":"Tourkochristou E, Mouzaki A, Triantos C. Gene polymorphisms and biological effects of vitamin D receptor on nonalcoholic fatty liver disease development and progression. Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms2409822.","journal-title":"Mol Sci"},{"key":"1749_CR20","doi-asserted-by":"publisher","first-page":"642653","DOI":"10.3389\/fonc.2021.642653","volume":"11","author":"I Adelani","year":"2021","unstructured":"Adelani I, Rotimi O, Maduagwu E, Rotimi S. Vitamin D: possible therapeutic roles in hepatocellular carcinoma. Frontiser. 2021;11:642653. https:\/\/doi.org\/10.3389\/fonc.2021.642653.","journal-title":"Frontiser"},{"key":"1749_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12881-019-0903","volume":"20","author":"N Hoan","year":"2019","unstructured":"Hoan N, Khuyen N, Giang D, Binh M, Toan N, Anh D. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus. BMC Med Genet. 2019;20:201. https:\/\/doi.org\/10.1186\/s12881-019-0903.","journal-title":"BMC Med Genet"},{"key":"1749_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/gtmb.2018.0770","volume":"23","author":"P Barooh","year":"2019","unstructured":"Barooh P, Saikia S, Bharadwaj R, Sarmah P, Bhattacha M, Goswami B. Role of VDR, GC, and CYP2R1 Polymorphisms in the development of hepatocellular carcinoma in hepatitis C Virus-infected patients. Genet Testing Mol Biomarkers. 2019;23:325. https:\/\/doi.org\/10.1089\/gtmb.2018.0770.","journal-title":"Genet Testing Mol Biomarkers"},{"key":"1749_CR23","doi-asserted-by":"publisher","first-page":"e64053","DOI":"10.1371\/journal.Pone.0064053","volume":"8","author":"C Lange","year":"2013","unstructured":"Lange C, Miki D, Ochi H, Nischalke H, Bojunga J, Bibert S. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated Hepatocellular Carcinoma Development. Plos One. 2013;8:e64053. https:\/\/doi.org\/10.1371\/journal.Pone.0064053.","journal-title":"Plos One"},{"key":"1749_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43066-020-00067-3","volume":"11","author":"GM Galal","year":"2021","unstructured":"Galal GM, Abudeif A, Ahmed NS, et al. Vitamin D receptor gene polymorphisms and risk of hepatocellular carcinoma in hepatitis C-related liver cirrhosis. Egypt Liver J. 2021;11:3. https:\/\/doi.org\/10.1186\/s43066-020-00067-3.","journal-title":"Egypt Liver J"},{"key":"1749_CR25","doi-asserted-by":"publisher","first-page":"10237","DOI":"10.3389\/bjbs.2021.10237","volume":"79","author":"M Neamatallah","year":"2022","unstructured":"Neamatallah M, Serria MS, El-Bendary M, et al. Association of vitamin D gene polymorphisms with HCV infection outcome. Br J Biomed Sci. 2022;79:10237. https:\/\/doi.org\/10.3389\/bjbs.2021.10237.","journal-title":"Br J Biomed Sci"},{"key":"1749_CR26","doi-asserted-by":"publisher","first-page":"00246","DOI":"10.3923\/ijcr.2017.26.35","volume":"7","author":"M Mohammed","year":"2017","unstructured":"Mohammed M, Omar N, Mohammed S, Deiab A. The significance of vitamin D receptor gene polymorphisms for susceptibility to hepatocellular carcinoma in subjects infected with hepatitis C virus. Gastroenterol Hepatol Open Access. 2017;7:00246. https:\/\/doi.org\/10.3923\/ijcr.2017.26.35.","journal-title":"Gastroenterol Hepatol Open Access"},{"key":"1749_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.20524\/aog.2022.0697","volume":"19","author":"Y Moemen","year":"2019","unstructured":"Moemen Y, Khalil F, Khalil A. FokI polymorphism in vitamin D receptor gene and its association with hepatocellular carcinoma in Egyptian patients with chronic liver disease. Meta Gene. 2019;19:104\u201310. https:\/\/doi.org\/10.20524\/aog.2022.0697.","journal-title":"Meta Gene"},{"key":"1749_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132. https:\/\/doi.org\/10.1002\/hep.24199.","journal-title":"Hepatology"},{"key":"1749_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"Y Yong","year":"2005","unstructured":"Yong Y, Lin H. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97. https:\/\/doi.org\/10.1038\/sj.cr.7290272.","journal-title":"Cell Res"},{"key":"1749_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5152\/tjg.2018.17570","volume":"29","author":"T Besheer","year":"2018","unstructured":"Besheer T, Arafa M, El-Maksoud MA, Elalfy H, Hasson A, Zalata K, et al. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: role of ABCB11 genotype polymorphism and plasma bile acid levels. Turk J Gastroenterol. 2018;29:299. https:\/\/doi.org\/10.5152\/tjg.2018.17570.","journal-title":"Turk J Gastroenterol"},{"key":"1749_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.20517\/2394-5079.2018.87","volume":"4","author":"EM Wu","year":"2018","unstructured":"Wu EM, Wong LL, Hernandez BY, Ji J-F, Jia W, Kwee SA, Kalathil S. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease\/steatohepatitis and liver transplantation. Hepatoma Res. 2018;4:66. https:\/\/doi.org\/10.20517\/2394-5079.2018.87.2032;12(7)984.DOI:10.3390\/biology12070984.","journal-title":"Hepatoma Res"},{"issue":"7","key":"1749_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/biology12070984","volume":"12","author":"R Nevola","year":"2023","unstructured":"Nevola R, Tortorella G, Rosato V, Rinaldi L, Imbriani S, Perillo P, et al. Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma. MDPI Biology. 2023;12(7):984. https:\/\/doi.org\/10.3390\/biology12070984.","journal-title":"MDPI Biology"},{"key":"1749_CR33","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/cncr.31406","volume":"124","author":"SW Yi","year":"2018","unstructured":"Yi SW, Choi JS, Yi JJ, Lee YH, Han KJ. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: a prospective cohort study in Korea. Cancer. 2018;124:2748\u201357. https:\/\/doi.org\/10.1002\/cncr.31406.","journal-title":"Cancer"},{"key":"1749_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/gtmb.2018.0170","volume":"23","author":"P Barooah","year":"2019","unstructured":"Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, et al. Role of VDR, GC, and CYP2R1 Polymorphisms in the development of hepatocellular carcinoma in hepatitis C virus-infected patients. Genet Test Mol Biomarkers. 2019;23:325\u201331. https:\/\/doi.org\/10.1089\/gtmb.2018.0170.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1749_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/09674845.2019.1680166","volume":"77","author":"I Raafat","year":"2020","unstructured":"Raafat I, Eshra KA, El-Sharaby RM, Eissa R, Saied SM, Amer I, El Sharawy S. Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis. Br J Biomed Sci. 2020;77:53\u20137. https:\/\/doi.org\/10.1080\/09674845.2019.1680166.","journal-title":"Br J Biomed Sci"},{"key":"1749_CR36","doi-asserted-by":"publisher","first-page":"615203","DOI":"10.3389\/fonc.2020.615203","volume":"10","author":"Y Du","year":"2021","unstructured":"Du Y, Du B, Fang X, Shu M, Zhang Y, Chung H, et al. ALT flare predicts hepatocellular carcinoma among antiviral treated patients with chronic hepatitis B: a cross-country cohort study. Front Oncol. 2021;10:615203. https:\/\/doi.org\/10.3389\/fonc.2020.615203.","journal-title":"Front Oncol"},{"key":"1749_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.14218\/JCTH.2021.00176","volume":"10","author":"A Turshudzhyan","year":"2022","unstructured":"Turshudzhyan A, Wu GY. Persistently rising alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: a review. J Clin Transl Hepatol. 2022;10:159\u201363. https:\/\/doi.org\/10.14218\/JCTH.2021.00176.","journal-title":"J Clin Transl Hepatol"},{"key":"1749_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.20524\/aog.2022.0697","volume":"35","author":"EP Tsounis","year":"2022","unstructured":"Tsounis EP, Tourkochristou E, Sapsani A, Aggeletopoulou I, Lourida T, Zisimopoulos K, et al. The role of vitamin D receptor polymorphisms in the course of chronic hepatitis C infection. Ann Gastroenterol. 2022;35:203\u201312. https:\/\/doi.org\/10.20524\/aog.2022.0697.","journal-title":"Ann Gastroenterol"},{"issue":"12","key":"1749_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116026","volume":"9","author":"Q Peng","year":"2014","unstructured":"Peng Q, Yang S, Lao X, Li R, Chen Z, Wang J, et al. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population. PLos One. 2014;9(12): e116026.","journal-title":"PLos One"},{"key":"1749_CR40","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.7314\/apjcp.2015.16.8.3339","volume":"16","author":"W Maneechay","year":"2015","unstructured":"Maneechay W, Boonpipattanapong T, Kanngurn S, Puttawibul P, Geater SL, Sangkhathat S. Single nucleotide polymorphisms in the Gc gene for vitamin D binding protein in common cancers in Thailand. Asian Pac J Cancer Prev. 2015;16:3339\u201344. https:\/\/doi.org\/10.7314\/apjcp.2015.16.8.3339.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1749_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2217\/bmm.11.88","volume":"6","author":"C Chupeerach","year":"2012","unstructured":"Chupeerach C, Tungtrongchitr A, Phonrat B, Schweigert FJ, Tungtrongchitr R, Preutthipan S. Association of Thr420Lys polymorphism in DBP gene with fat-soluble vitamins and low radial bone mineral density in postmenopausal Thai women. Biomark Med. 2012;6:103\u20138. https:\/\/doi.org\/10.2217\/bmm.11.88.","journal-title":"Biomark Med"},{"issue":"33","key":"1749_CR42","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/MD.0000000000001370","volume":"94","author":"ZM Dai","year":"2015","unstructured":"Dai ZM, Fei YL, Zhang WG, Liu J, Cao XM, Qu QM, et al. Association of vitamin D receptor Cdx-2 polymorphism with cancer risk a meta-analysis. Medicine (Baltimore). 2015;94(33):1370. https:\/\/doi.org\/10.1097\/MD.0000000000001370.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1749_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrg2361","volume":"9","author":"M Slatkin","year":"2008","unstructured":"Slatkin M. Linkage disequilibrium-understanding the evolutionary past and mapping the medical future. Nat Rev Genet. 2008;9(6):477\u201385. https:\/\/doi.org\/10.1038\/nrg2361.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"1749_CR44","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/1055-9965","volume":"19","author":"SC Chuang","year":"2010","unstructured":"Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1261\u20138. https:\/\/doi.org\/10.1158\/1055-9965.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1749_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/v15020559","volume":"15","author":"TH Yang","year":"2023","unstructured":"Yang TH, Chan C, Yang PJ, Huang YH, Lee MH. Genetic susceptibility to hepatocellular carcinoma in patients with chronic hepatitis virus infection. Viruses. 2023;15:559. https:\/\/doi.org\/10.3390\/v15020559.","journal-title":"Viruses"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01749-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T03:03:59Z","timestamp":1702004639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01749-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2800188\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human subjects in our study were carried out in compliance with the guidelines for clinical research established by the Human Ethical Clearance Committee in accordance with the Helsinki Declaration (1964) and with the consent of the human subject. Tropical Medicine Department of the Mansoura University Hospital Ethical Clearance Committee approved the study (Code No. MS.21.09.1671). Each patient's informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}